Literature DB >> 16323135

Rapid dynamics of polyomavirus type BK in renal transplant recipients.

Georg A Funk1, Jurg Steiger, Hans H Hirsch.   

Abstract

BACKGROUND: Polyomavirus type BK-associated nephropathy (PVAN) is an emerging cause of early renal transplant failure. No specific antiviral treatment has been established. Current interventions rely on improving immune functions by reducing immunosuppression. In patients with PVAN, a high BK virus (BKV) load is detectable in plasma. However, the relationship between BKV replication and disease is not well understood.
METHODS: In a retrospective analysis of BKV plasma load in renal transplant recipients undergoing allograft nephrectomy (n = 3) or changes in immunosuppressive regimen (n = 12), we calculated viral clearance rates and generation times and estimated the loss of BKV-infected renal cells.
RESULTS: After nephrectomy, BKV clearance was fast (viral half-life [t(1/2)], 1-2 h) or moderately fast (t(1/2), 20-38 h), depending on the sampling density, but it was independent of continued immunosuppressive regimens. After changing immunosuppressive regimens, BKV was cleared with a t(1/2) of 6 h-17 days. Using the basic reproductive ratio, the efficacies of intervention ranged from 7% to 83% (mean, 28%; median, 22%).
CONCLUSION: The results emphasize that high-level BKV replication is a major pathogenetic factor that may have implications for genome rearrangements, immune evasion, and antiviral resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16323135     DOI: 10.1086/498530

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Modeling Immune Response to BK Virus Infection and Donor Kidney in Renal Transplant Recipients.

Authors:  H T Banks; Shuhua Hu; Kathryn Link; Eric S Rosenberg; Sheila Mitsuma; Lauren Rosario
Journal:  Inverse Probl Sci Eng       Date:  2015-03-13       Impact factor: 1.950

2.  VP-1 quasispecies in human infection with polyomavirus BK.

Authors:  Chunqing Luo; Hans H Hirsch; Jeffrey Kant; Parmjeet Randhawa
Journal:  J Med Virol       Date:  2011-11-03       Impact factor: 2.327

Review 3.  Monitoring and managing viral infections in pediatric renal transplant recipients.

Authors:  Patrizia Comoli; Fabrizio Ginevri
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

4.  Antirejection treatment in kidney transplant patients with BK viruria.

Authors:  Liise K Kayler; Ibrahim Batal; Ravi Mohanka; Claire Morgan; Amit Basu; Ron Shapiro; Parmjeet S Randhawa
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

Review 5.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 6.  Viral infection in renal transplant recipients.

Authors:  Jovana Cukuranovic; Sladjana Ugrenovic; Ivan Jovanovic; Milan Visnjic; Vladisav Stefanovic
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 7.  Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature.

Authors:  Joan C Y Ng; Marianna Leung; Alissa J Wright; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 5.577

8.  Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.

Authors:  Rainer Gosert; Christine H Rinaldo; Georg A Funk; Adrian Egli; Emilio Ramos; Cinthia B Drachenberg; Hans H Hirsch
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

Review 9.  Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.

Authors:  Patrizia Comoli; Michela Cioni; Sabrina Basso; Chiara Gagliardone; Leonardo Potenza; Enrico Verrina; Mario Luppi; Marco Zecca; Gian Marco Ghiggeri; Fabrizio Ginevri
Journal:  Clin Dev Immunol       Date:  2013-08-13

10.  Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.

Authors:  H H Hirsch; F Vincenti; S Friman; M Tuncer; F Citterio; A Wiecek; E H Scheuermann; M Klinger; G Russ; M D Pescovitz; H Prestele
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.